Acoustic Neuroma Treatment in Turkey

What Acoustic Neuroma Is and Typical Symptoms

An acoustic neuroma, or vestibular schwannoma, is a benign tumour originating on the vestibulocochlear nerve (eighth cranial nerve). This nerve connects the inner ear to the brain, carrying sound and balance signals. Because the tumour arises from Schwann cells, it is non-cancerous and does not spread to distant organs. However, as it enlarges within the internal auditory canal and cerebellopontine angle, it can compress adjacent cranial nerves, blood vessels, and the brainstem.

Symptoms typically develop gradually and depend on tumour size, location, and growth rate:

• Unilateral hearing loss: Progressive hearing reduction in one ear is the most frequent initial sign.
• Tinnitus: High-pitched ringing, buzzing, or hissing sounds in the affected ear.
• Balance problems: Mild unsteadiness or dizziness caused by vestibular nerve disturbance.
• Facial numbness: Tingling or reduced sensation when the tumour impinges on the trigeminal nerve.
• Ear fullness and headaches: A feeling of blockage in the ear or tension headaches.

How Acoustic Neuroma Is Diagnosed

Accurate evaluation requires modern neuroimaging and audiological testing. When visiting neurosurgery and ENT departments in Turkey, the clinical team assesses symptoms, baseline nerve function, and previous test results.

Hospitals typically carry out or verify several standard investigations:

• Contrast-enhanced MRI: Magnetic resonance imaging with gadolinium contrast remains the reference standard. It detects lesions smaller than two millimetres and clarifies anatomical relationships with the brainstem and facial nerve.
• Pure tone and speech audiometry: Measures hearing thresholds and speech comprehension in each ear.
• Vestibular testing: Videonystagmography examines inner-ear balance responses.
• High-resolution temporal bone CT: Evaluates bony architecture when surgery is planned or if MRI is contraindicated.

Patients should bring historical medical records, including past MRI or CT scans in DICOM format, previous audiograms, clinical letters, and a current medication list. Having earlier scans allows the neurosurgeon to measure tumour growth velocity accurately.

Treatment Options and When Each Is Considered

Management depends on individual factors. Clinical decisions are made by the treating medical team after reviewing imaging, symptom progression, patient age, baseline hearing, and tumour size.

Following treatment, selected patients benefit from rehabilitation to help the brain adapt to balance changes.

Planning Your Treatment and Medical Travel to Turkey

Careful planning helps overseas patients undergo assessment and treatment safely. Before travelling, patients typically submit existing MRI scans and audiological tests for preliminary review by a neurosurgical specialist in Turkey.

Expected timelines vary by clinical pathway:

• Consultation and restaging: Allow one to two days for initial examinations, repeated audiometry, and required check-ups and diagnostics.
• Radiosurgery pathway: Non-invasive stereotactic radiosurgery generally involves four to seven days in Turkey for imaging planning, radiation delivery, and initial review.
• Microsurgery pathway: Surgical removal generally requires ten to fourteen days. This includes four to seven days of inpatient hospital care, followed by wound monitoring and travel clearance.

Before returning home, request a translated medical summary, operative notes, and imaging copies. Follow-up monitoring involves periodic MRI scans arranged with your local physician.

Warning Signs and When Travel Is Not Advisable

Although acoustic neuromas are slow-growing, certain symptoms require immediate medical intervention rather than international transit. Flying with unstable intracranial pathology carries distinct risks.

You should not travel abroad and must seek emergency medical care locally if you experience:

• Signs of raised intracranial pressure: Severe morning headaches with nausea, vomiting, or blurred vision.
• Sudden neurological deficits: Acute facial drooping, inability to shut the eyelid, or profound facial numbness.
• Severe gait ataxia: Inability to walk steadily or recurrent falls.
• Swallowing or speech difficulty: Choking sensations or hoarseness indicating lower cranial nerve involvement.
• Altered alertness: Confusion, persistent drowsiness, or signs of secondary hydrocephalus.

Always obtain formal clearance from your treating specialist before travelling.